4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pharma Foods International Co., Ltd. (2929) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kyoto, Japan. Its market capitalization is roughly JPY 21 billion.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory.
Interactive charts & full statements → Open the 2929 valuation workbench →
| Income statement | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Total Revenue | — | JPY 62.1B | JPY 68.6B | JPY 60.2B |
| Gross Profit | — | JPY 48.8B | JPY 55.3B | JPY 48.1B |
| Operating Income (EBIT) | JPY 2.4B | JPY 5.2B | JPY 3.7B | JPY 1.1B |
| Net Income | — | JPY 3.2B | JPY 3.1B | (JPY 374M) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Dividends Paid | — | (JPY 626M) | (JPY 578M) | (JPY 871M) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|
| Total Assets | JPY 36.6B | JPY 36.2B | JPY 31.2B |
| Total Liabilities | JPY 25.0B | JPY 26.6B | JPY 24.1B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2929 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms